Arthritis and Rheumatic Care Center - South Miami Arthritis pain clinic

Our doctors are proud to announce their participation in the Corrona study...

Click here for
Study Qualifying Information

RHEUMATOID ARTHRITIS STUDY

The CORRONA Data Collection Program is a registry study which collects information from physicians and patients on care and outcomes of patients with Rheumatoid Arthritis (RA) in the US.

As part of this data collection you are being asked to participate in a study called “Treating to Target (T2T) for patients with Rheumatoid Arthritis in US population: Outcomes and feasibility.” This data will be a valuable tool in assessing whether it is realistic to use the (T2T) approach to improve the outcomes in US patients who suffer with RA.

________________________________________________________

What is the goal of this study?

To determine whether persons who are treated to target, with the goal of reaching low disease activity levels, have better treatment outcomes than those treated with usual care. Subjects in the Treat to Target (T2T) group may be required to return to the doctor's office more often, and treated aggressively until low disease activity levels are reached (unless there are medical reasons not to).

Why is this research important?

More information is needed about whether the Treat to Target (T2) approach to treating active RA is more effective than traditional methods used by U.S. Rheumatologists. It is also important to understand reasons why this approach may not work, and barriers or challenges that may exist.

What are you asking me to do?

Participants from offices that have been randomly chosen to the Treat to Target (T2T) group will be asked to come to their Rheumatologist's office as often as monthly until they reach low disease activity. Questionnaires are collected at each visit and blood samples are collected every 3 months.

Why should I participate?

The decision to participate is yours alone, but we hope that the information gained from this study will help us better understand whether a treat to target approach to treating RA can help improve medical outcomes of persons with the disease in the U.S.

______________________________________________________________________________________________________________

For a complete study description, please visit the official listings below:

ClinicalTrials.gov: http://clinicaltrials.gov/ct2/show/study/NCT01407419?show_desc=Y#desc
Corrona Study Site: http://www.corrona.org/p/index.html